121 related articles for article (PubMed ID: 1556263)
1. T-cell receptor variable region gene expression in cutaneous T-cell lymphomas.
Gilks CB; Ho VC; Gascoyne RD; Ellison DJ
J Cutan Pathol; 1992 Feb; 19(1):21-6. PubMed ID: 1556263
[TBL] [Abstract][Full Text] [Related]
2. Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.
Fivenson DP; Hanson CA; Nickoloff BJ
J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):717-23. PubMed ID: 7929915
[TBL] [Abstract][Full Text] [Related]
3. Immunodiagnosis in cutaneous T cell lymphoma: how does gene expression of the variable region of the T cell receptor fit into the diagnostic and pathophysiological picture of T cell neoplasia.
Fivenson DP; Nickoloff BJ
J Cutan Pathol; 1992 Feb; 19(1):1-5. PubMed ID: 1556262
[No Abstract] [Full Text] [Related]
4. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome.
Whittaker SJ; Smith NP; Jones RR; Luzzatto L
Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197
[TBL] [Abstract][Full Text] [Related]
5. Intraepidermal localization of the clone in cutaneous T-cell lymphoma.
Bagot M; Wechsler J; Lescs MC; Revuz J; Farcet JP; Gaulard P
J Am Acad Dermatol; 1992 Oct; 27(4):589-93. PubMed ID: 1357011
[TBL] [Abstract][Full Text] [Related]
6. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
7. T-cell receptor variable region genes in cutaneous T-cell lymphomas.
Thor Straten P; Ralfkiaer E; Hendriks J; Seremet T; Vejlsgaard GL; Zeuthen J
Br J Dermatol; 1998 Jan; 138(1):3-12. PubMed ID: 9536217
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders.
Zelickson BD; Peters MS; Muller SA; Thibodeau SN; Lust JA; Quam LM; Pittelkow MR
J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):787-96. PubMed ID: 1839392
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous T-cell lymphoma cells employ a restricted range of T-cell antigen receptor variable region genes.
Jack AS; Boylston AW; Carrel S; Grigor I
Am J Pathol; 1990 Jan; 136(1):17-21. PubMed ID: 2297046
[TBL] [Abstract][Full Text] [Related]
10. [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook].
Bagot M
Bull Acad Natl Med; 1998; 182(5):927-37; discussion 937-8. PubMed ID: 9735499
[TBL] [Abstract][Full Text] [Related]
11. Anti-V region antibodies as "almost clonotypic" reagents for the study of cutaneous T cell lymphomas and leukemias.
Charley M; McCoy JP; Deng JS; Jegasothy B
J Invest Dermatol; 1990 Nov; 95(5):614-7. PubMed ID: 2146326
[TBL] [Abstract][Full Text] [Related]
12. [Progress in the diagnosis and physiopathology of cutaneous lymphoma].
Bagot M
Ann Dermatol Venereol; 1993; 120(1):43-52. PubMed ID: 8393314
[TBL] [Abstract][Full Text] [Related]
13. T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin.
Potoczna N; Boehncke WH; Nestle FO; Küenzlen C; Sterry W; Burg G; Dummer R
J Cutan Pathol; 1996 Aug; 23(4):298-305. PubMed ID: 8864915
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor variable (V) gene usage by lymphoid populations in T-cell lymphoma.
Smith JL; Lane AC; Hodges E; Reynolds WM; Howell WM; Jones DB; Janson CH
J Pathol; 1992 Feb; 166(2):109-12. PubMed ID: 1560311
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor V beta-family usage in primary cutaneous and primary nodal T-cell non-Hodgkin's lymphomas.
Preesman AH; Hu HZ; Tilanus MG; de Geus B; Schuurman HJ; Reitsma R; van Wichen DF; van Vloten WA; de Weger RA
J Invest Dermatol; 1992 Nov; 99(5):587-93. PubMed ID: 1331246
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas.
Bakels V; van Oostveen JW; van der Putte SC; Meijer CJ; Willemze R
Am J Pathol; 1997 Jun; 150(6):1941-9. PubMed ID: 9176388
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of T-cell receptor beta genes in cutaneous T-cell lymphoma reveals Jbeta1 bias.
Morgan SM; Hodges E; Mitchell TJ; Harris S; Whittaker SJ; Smith JL
J Invest Dermatol; 2006 Aug; 126(8):1893-9. PubMed ID: 16741518
[TBL] [Abstract][Full Text] [Related]
18. T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.
Fivenson DP; Saed GM; Beck ER; Dunstan RW; Moore PF
J Invest Dermatol; 1994 Feb; 102(2):227-30. PubMed ID: 7906287
[TBL] [Abstract][Full Text] [Related]
19. Application of a multiprobe RNase protection assay and junctional sequences to define V beta gene diversity in Sezary syndrome.
Kono DH; Baccala R; Balderas RS; Kovac SJ; Heald PW; Edelson RL; Theofilopoulos AN
Am J Pathol; 1992 Apr; 140(4):823-30. PubMed ID: 1562047
[TBL] [Abstract][Full Text] [Related]
20. T-cell receptor gamma gene rearrangement in cutaneous T-cell lymphoma: comparative study of polymerase chain reaction with denaturing gradient gel electrophoresis and GeneScan analysis.
Goeldel AL; Cornillet-Lefebvre P; Durlach A; Birembaut P; Bernard P; Nguyen P; Grange F
Br J Dermatol; 2010 Apr; 162(4):822-9. PubMed ID: 19906072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
